Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iridex (IRIX) EBITDA (2016 - 2026)

Iridex has reported EBITDA over the past 17 years, most recently at $1.6 million for Q1 2026.

  • For Q1 2026, EBITDA fell 72.49% year-over-year to $1.6 million; the TTM value through Jan 2026 reached -$921000.0, up 50.43%, while the annual FY2026 figure was -$921000.0, 50.4% up from the prior year.
  • EBITDA for Q1 2026 was $1.6 million at Iridex, up from -$1.4 million in the prior quarter.
  • Over five years, EBITDA peaked at $5.9 million in Q4 2024 and troughed at -$3.3 million in Q1 2024.
  • A 5-year average of -$1.3 million and a median of -$1.7 million in 2022 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 118.51% in 2023 and later skyrocketed 292.89% in 2024.
  • Year by year, EBITDA stood at -$1.4 million in 2022, then plummeted by 118.51% to -$3.1 million in 2023, then skyrocketed by 292.89% to $5.9 million in 2024, then tumbled by 123.74% to -$1.4 million in 2025, then skyrocketed by 215.88% to $1.6 million in 2026.
  • Business Quant data shows EBITDA for IRIX at $1.6 million in Q1 2026, -$1.4 million in Q3 2025, and -$940000.0 in Q2 2025.